Nayab Tahir1,2,3, Asadullah Madni2, Alexandra Correia3, Mubashar Rehman4, Vimalkumar Balasubramanian3, Muhammad Muzamil Khan2, Hélder A Santos3,5. 1. College of Pharmacy, University of Sargodha, Sargodha, Pakistan. 2. Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan. 3. Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland. 4. Department of Pharmacy, The University of central Pujnab, Lahore, Pakistan. 5. Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki FI-00014, Finland.
Abstract
Background: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method. Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), lecithin, and 1,2-distearoyl-Sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000 (DSPE-PEG 2000) were selected as structural components. Results: The mean particle size was 173-208 nm, with an encapsulation efficiency of 17.8±1.9 to 43.8±4.4% and 40.3±0.6 to 59. 8±1.4% for DOX.HCl and DOX base, respectively. The drug release profile was in the range 33-57% in 24 hours and followed the Higuchi model (R2=0.9867-0.9450) and Fickian diffusion (n<0.5). However, the release of DOX base was slower than DOX.HCl. The in vitro cytotoxicity studies and confocal imaging showed safety, good biocompatibility, and a higher degree of particle internalization. The higher internalization of DOX base was attributed to higher permeability of lipophilic component and better hydrophobic interaction of particles with cell membranes. Compared to the free DOX, the DOX.HCl and DOX base loaded LPHNPs showed higher antiproliferation effects in MDA-MB231 and PC3 cells. Conclusion: Therefore, LPHNPs have provided a potential drug delivery strategy for safe, controlled delivery of both hydrophilic and lipophilic form of DOX in cancer cells.
Background: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method. Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), lecithin, and 1,2-distearoyl-Sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000 (DSPE-PEG 2000) were selected as structural components. Results: The mean particle size was 173-208 nm, with an encapsulation efficiency of 17.8±1.9 to 43.8±4.4% and 40.3±0.6 to 59. 8±1.4% for DOX.HCl and DOX base, respectively. The drug release profile was in the range 33-57% in 24 hours and followed the Higuchi model (R2=0.9867-0.9450) and Fickian diffusion (n<0.5). However, the release of DOX base was slower than DOX.HCl. The in vitro cytotoxicity studies and confocal imaging showed safety, good biocompatibility, and a higher degree of particle internalization. The higher internalization of DOX base was attributed to higher permeability of lipophilic component and better hydrophobic interaction of particles with cell membranes. Compared to the free DOX, the DOX.HCl and DOX base loaded LPHNPs showed higher antiproliferation effects in MDA-MB231 and PC3 cells. Conclusion: Therefore, LPHNPs have provided a potential drug delivery strategy for safe, controlled delivery of both hydrophilic and lipophilic form of DOX in cancer cells.
Entities:
Keywords:
breast cancer; doxorubicin; drug delivery; lipid polymer hybrid; nanotechnology
Authors: T Musumeci; C A Ventura; I Giannone; B Ruozi; L Montenegro; R Pignatello; G Puglisi Journal: Int J Pharm Date: 2006-06-23 Impact factor: 5.875
Authors: Dalia A Gaber; Hessah S Alhawas; Fatimah A Alfadhel; Siham A Abdoun; Amal M Alsubaiyel; Rehab M Alsawi Journal: Drug Des Devel Ther Date: 2020-12-07 Impact factor: 4.162
Authors: Mohammed A Attia; Eman T Enan; Abdullah A Hashish; Sherif M H El-Kannishy; Ahmed R Gardouh; Mona K Tawfik; Salwa Faisal; Amr El-Mistekawy; Ayman Salama; Suliman Y Alomar; Amira H Eltrawy; Sheka Yagub Aloyouni; Sawsan A Zaitone Journal: Biomolecules Date: 2021-01-15